2,4-Diamino-6-(bis-2-chloroethyl)aminomethyl pteridine M. Abu KhaledRichard D. MorinJ. Patrick Daugherty Original Articles Pages: 73 - 74
Daunomycin-arachidonic acid complex as a potential new antitumor agent T. SasakiY. TsukadaH. Hirai Original Articles Pages: 75 - 77
High-dose adriamycin (ADM) and cis-platinum (DDP) in advanced soft-tissue sarcomas and invasive thymomas T. H. KlippsteinP. S. MitrouL. Bergmann Original Articles Pages: 78 - 81
Sodium thiosulfate inhibits cis-diamminedichloroplatinum (II) activity Jiro UozumiMinoru IshizawaTsuneo Baba Original Articles Pages: 82 - 85
Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia Masaaki IigoAkio Hoshi Original Articles Pages: 86 - 90
The bioavailability of oral intermediate-dose methotrexate V. J. HarveyM. L. SlevinP. Turner Original Articles Pages: 91 - 94
A randomized trial of adriamycin, cyclophosphamide, ftorafur (ACF) and adriamycin, cyclophosphamide, ftorafur, methotrexate (ACFM) in patients with advanced breast cancer Katsuhiro InoueMakoto OgawaKoichi Adachi Original Articles Pages: 95 - 99
A phase I toxicity study of human rDNA interferon in patients with solid tumours J. WagstaffG. ChadwickD. Crowther Original Articles Pages: 100 - 105
Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer Simon G. AllanAnna GregorGraham K. Crompton Original Articles Pages: 106 - 108
Cell survival in four ovarian carcinoma xenografts following in vitro exposure to melphalan, cisplatin and cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA, JM8) Adrian C. JonesPatricia A. WilsonG. Gordon Steel Original Articles Pages: 109 - 113
Pharmacokinetics of vindesine bolus and infusion Don V. Jackson Jr.V. Sagar SethiCharles L. Spurr Original Articles Pages: 114 - 119
Hepatic intra-arterial infusion of vincristine Don V. Jackson Jr.Frederick Richards IIJ. Michael Sterchi Original Articles Pages: 120 - 122
Randomized crossover study of the antiemetic activity of levonantradol and metoclopramide in cancer patients receiving chemotherapy Manfred E. HeimWolfgang QueißerHans-Peter Altenburg Original Articles Pages: 123 - 125
Potentiation by amphotericin B of the cytotoxicity of anticancer agents against MOPC-315 plasmacytoma and lewis lung carcinoma Frederick ValerioteJulia DieckmanGerald Medoff Original Articles Pages: 126 - 130
Penetration and binding of vinblastine and 5-fluorouracil in cellular spheroids Thore NedermanJörgen Carlsson Original Articles Pages: 131 - 135
Phase-I trial of combination therapy with continuous-infusion MMPR and continuous-infusion 5-FU William P. PetersGeoffrey WeissDonald W. Kufe Original Articles Pages: 136 - 138
Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicity Tina ColomboMaurizio D'Incalci Original Articles Pages: 139 - 141
CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer Krsto KolarićAnton RothJožica Červek Original Articles Pages: 142 - 144
Expression of cell surface P-glycoprotein by an Adriamycin-resistant murine fibrosarcoma Raffaella GiavazziNorbert KartnerIan R. Hart Short Communication Pages: 145 - 147
Phase-II study of vindesine and hexamethylmelamine in patients with relapsing small cell carcinoma of the lung Rudolf A. JossJean-Paul Obrechtthe Swiss Group for Clinical Cancer Research (SAKK) Short Communication Pages: 148 - 149
Amsacrine administration: A precautionary note Constance EngelkingPhyllis SullivanZalmen A. Arlin Letter to the Editors Pages: 150 - 150